Treatment- related toxicities in patients with squamous cell carcinoma of the head and neck (SCCHN)

被引:0
|
作者
Yood, M. Ulcickas
Wang, P. Feng
Alford, S. Hensley
Oliveria, S.
Wells, K.
Phillips, S.
Ali, H.
O'Malley, C. D.
机构
[1] EpiSource LLC, Hamden, CT USA
[2] Amgen Inc, Cambridge, MA USA
[3] Henry Ford Hlth Syst, Detroit, MI USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e17041
引用
收藏
页数:1
相关论文
共 50 条
  • [1] TREATMENT-RELATED TOXICITIES IN PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)
    Yood, M. U.
    Wang, F.
    Zhao, Z.
    Alford, S. H.
    Oliveria, S.
    Wells, K.
    Phillips, S.
    Ali, H.
    O'Malley, C.
    Barber, B.
    VALUE IN HEALTH, 2009, 12 (07) : A225 - A225
  • [2] Treatment-related toxicities in patients with squamous cell carcinoma of the head and neck (SCCHN)
    Yood, M. Ulcickas
    Wang, P. Feng
    Zhao, Z.
    Alford, S. Hensley
    Oliveria, S.
    Wells, K.
    Phillips, S.
    Ali, H.
    O'Malley, C.
    EJC SUPPLEMENTS, 2009, 7 (02): : 477 - 477
  • [3] Toxicities of systemic agents in squamous cell carcinoma of the head and neck (SCCHN); A new perspective in the era of immunotherapy
    Saba, Nabil F.
    Mody, Mayur D.
    Tan, Elaine S.
    Gill, Harpaul S.
    Rinaldo, Alessandra
    Takes, Robert P.
    Strojan, Primoz
    Hartl, Dana M.
    Vermorken, Jan B.
    Haigentz, Missak, Jr.
    Ferlito, Alfio
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 115 : 50 - 58
  • [4] Future perspectives in the treatment of chemotherapy and radiotherapy for squamous cell carcinoma of the head and neck (SCCHN)
    Herchenhorn, D
    2ND WORLD CONGRESS OF THE INTERNATIONAL FEDERATION OF HEAD AND NECK ONCOLOGIC SOCIETIES, 2002, : 39 - 50
  • [5] REAL-WORLD TREATMENT PATTERNS AMONG PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) IN CANADA
    Byrne, K.
    Hallworth, P.
    Monafred, Tahami A. A.
    Moshyk, G.
    Shaw, J. W.
    VALUE IN HEALTH, 2017, 20 (05) : A138 - A139
  • [6] Outcomes of HIV patients treated with chemoradiotherapy (CRT) for squamous cell carcinoma of the head and neck (SCCHN)
    Mourad, Waleed Fouad
    Hu, Kenneth
    Shourbaji, Rania Ayman
    Li, Zujun
    Culliney, Bruce
    Harrison, Louis Benjamin
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] IMMUNOMODULATION WITH DIETHYLDITHIOCARBAMATE (DDTC) IN PATIENTS WITH RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)
    PAREDES, J
    REUBEN, J
    HERSH, EM
    ROBBINS, T
    MCCARTHY, K
    HONG, WK
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 405 - 405
  • [8] PATIENT REPORTED HRQOL IN PATIENTS WITH STAGE IV SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)
    Byrne, K.
    Hallworth, P.
    Zanotti, G.
    VALUE IN HEALTH, 2017, 20 (05) : A120 - A121
  • [9] Efficacy of neck treatment in patients with head and neck squamous cell carcinoma
    Buck, Gabriela
    Huguenin, Pia
    Stoeckli, Sandro J.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2008, 30 (01): : 50 - 57
  • [10] TREATMENT OF NECK IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF HEAD AND NECK
    JESSE, RH
    FLETCHER, GH
    CANCER, 1977, 39 (02) : 868 - 872